ApicHope Pharmaceutical (SHE:300723) subsidiary obtained drug registration from China's medical products regulator for sertraline hydrochloride oral solution.
The drug is used to treat depression and obsessive-compulsive disorder, according to a Thursday aftermarket filing with the Shenzhen bourse.
Shares of the pharmaceutical company were down 3% Friday.